البلد: نيوزيلاندا
اللغة: الإنجليزية
المصدر: Medsafe (Medicines Safety Authority)
Oxaliplatin 100mg
Pfizer New Zealand Limited
Oxaliplatin 100 mg
100 mg
Powder for injection
Active: Oxaliplatin 100mg Excipient: Lactose
Vial, glass, Type 1, 50mL with bromobutyl rubber stopper and Al seal 10 x 100mg, 1 g
Prescription
Prescription
Laurus Labs Limited
Oxaliplatin, in combination with 5-fluorouracil and folinic acid, is indicated for: · Adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour.
Package - Contents - Shelf Life: Vial, glass, Type 1, 50mL with bromobutyl rubber stopper and Al seal 10 x 100mg - 1 g - 24 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, Type 1, 50mL with bromobutyl rubber stopper and Al seal 1 x 100mg - 100 mg - 24 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, Type 1, 50mL with bromobutyl rubber stopper and Al seal 5 x 100mg - 500 mg - 24 months from date of manufacture stored at or below 25°C protect from light
2011-01-25
_Oxaliplatin-PF Data Sheet _ _26 June 2012_ DATA SHEET Page 1 of 19 OXALIPLATIN-PF POWDER FOR INJECTION, OXALIPLATIN 50 MG AND 100 MG VIALS (NOT MARKETED) CONCENTRATED SOLUTION FOR INJECTION, OXALIPLATIN 5 MG/ML (NOT MARKETED) DESCRIPTION Oxaliplatin is designated chemically as [_SP_-4-2]-(1_R_,2_R_)-(cyclohexane-1,2-diamine-k 2 _N,N_´(oxalato(2-)- k 2 _O_ _1_ ,_O_ _2_ ]platinum(II)._ _ The empirical formula of oxaliplatin is C 8 H 14 N 2 O 4 Pt and its molecular weight is 397.3. Oxaliplatin has the following chemical structure: CAS Number: 61 825-94-3 Oxaliplatin is a white to off-white crystalline powder. It is slightly soluble in water, very slightly soluble in methanol and practically insoluble in ethanol. Oxaliplatin-PF powder for injection also contains lactose. Oxaliplatin-PF concentrated solution for injection also contains water for injection. PHARMACOLOGY PHARMACODYNAMICS Oxaliplatin is an antineoplastic medicine belonging to a class of platinum based compounds in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and an oxalate group. Oxaliplatin is a single enantiomer, the cis-[oxalato(trans-_l_-1,2-DACH) platinum]. Oxaliplatin exhibits a wide spectrum of both _in vitro _cytotoxicity and _in vivo _antitumour activity in a variety of tumour model systems, including human colorectal cancer models. Oxaliplatin also demonstrates _in vitro _and _in vivo _activity in various cisplatin resistant models. A synergistic cytotoxic action has been observed in combination with fluorouracil both _in vitro _and _in vivo_._ _ Studies on the mechanism of action of oxaliplatin, although not completely elucidated, show that اقرأ الوثيقة كاملة